|Page (1) of 1 - 03/11/13||email article||print page|
Chimerix, a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it has publicly filed a registration statement on Form S-1 with the SEC relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not been determined.
|Chimerix Files Registration Statement for Proposed IPO|
Source:GrabNetworks (c). All Rights Reserved